Scholars Central

Conference abstractPublished 18 Apr 2022

Persistence of clinically-relevant levels of SARS-CoV2 subgenomic RNA (sgRNA) in non-immunocompromised individuals

Authors: Merlin Davies, Laura R Bramwell, Nicola Jeffery, Ben Bunce, Ben P Lee, Bridget Knight, Cressida Auckland, Jane AH Masoli, Lorna W Harries

Institute of Clinical and Biomedical Sciences, University of Exeter, UK Royal Devon and Exeter NHS Foundation Trust, Royal Devon and Exeter Hospital, UK Royal Devon and Exeter Foundation Trust, UK Healthcare for Older People, Royal Devon and Exeter NHS Foundation Trust, UK

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Prevention of ongoing transmission of SARS-CoV-2 is an essential component of managing the current pandemic. A key prerequisite for this is an accurate understanding the kinetics of viral clearance, likely infectious duration and the circumstances under which clinically relevant levels of active and potentially infectious virus may persist. We carried out an assessment of E gene and sgRNA viral load as a function of disease severity in a retrospective collection of swab samples from 176 PCR-confirmed individuals. We then determined the viral clearance dynamics of E gene and sgRNA viral sequences in serial samples from a subset of 17 individuals, and assessed duration of positive test result in a further set of 65 E gene positive individuals and 32 sgRNA positive individuals. We found that both E gene and sgRNA viral load correlated with the presence of COVID-19 symptoms, and that whilst sgRNA viral load declined before E gene viral load, some individuals retained both sgRNA and E gene positivity for extended periods of time of up to 68 days. 13% of sgRNA positive cases still exhibited clinically-relevant levels of virus after 10 days, and that these individuals were without clinical features previously associated with prolonged viral clearance times. Our results suggest that care needs to be taken in the assumption that people other than older adults with frailty or those with immunocompromise will be clear of infectious virus after 10 days. We have shown that active virus may persist after this period, which may lead to increased onward transmission risk. We suggest when onward transmission would pose a serious public health threat, for example return to residential care after hospitalisation, that inpatient hospital infection control policies should not be relaxed without evidence of negative test.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Infectious Diseases & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Infectious Diseases & Therapy
  • SubjectInfectious Diseases
  • BylineArticles whose byline prints “Merlin Davies”
  • BylineArticles whose byline prints “Laura R Bramwell”
  • BylineArticles whose byline prints “Nicola Jeffery”
  • BylineArticles whose byline prints “Ben Bunce”
  • BylineArticles whose byline prints “Ben P Lee”
  • BylineArticles whose byline prints “Bridget Knight”
  • BylineArticles whose byline prints “Cressida Auckland”
  • BylineArticles whose byline prints “Jane AH Masoli”